Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines

Details for Australian Patent Application No. 2009201589 (hide)

Owner Immatics Biotechnologies GmbH

Inventors Flohr, Christian; Lewandrowski, Peter

Agent Pizzeys

Pub. Number AU-A-2009201589

Priority 61/047,669 24.04.08 US; 08008292.8 30.04.08 EP

Filing date 23 April 2009

Wipo publication date 12 November 2009

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61P 35/00 (2006.01) Antineoplastic agents

C07K 7/02 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/74 (2006.01) Peptides having more than 20 amino acids

Event Publications

14 May 2009 Complete Application Filed

  Priority application(s): 61/047,669 24.04.08 US; 08008292.8 30.04.08 EP

12 November 2009 Application Open to Public Inspection

  Published as AU-A-2009201589

28 April 2011 Alteration of Name

  The name of the applicant has been altered to immatics biotechnologies GmbH

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009201590-Stanchion and curtain for a side of a vehicle

2009201588-Growth factor modified protein matrices for tissue engineering